Article info
PDFBasic and translational research
Extended report
Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation
- Correspondence to Professor Susan D Brain, Cardiovascular Division, BHF Cardiovascular Centre of Excellence and Centre of Integrative Biomedicine, King's College London, London SE1 9NH, UK; sue.brain{at}kcl.ac.uk
Citation
Transient receptor potential canonical 5 (TRPC5) protects against pain and vascular inflammation in arthritis and joint inflammation
Publication history
- Received November 10, 2015
- Revised April 6, 2016
- Accepted April 9, 2016
- First published May 10, 2016.
Online issue publication
November 13, 2020
Article Versions
- Previous version (13 November 2020).
- Previous version (13 November 2020).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://www.bmj.com/company/products-services/rights-and-licensing/ This is an Open Access article distributed in accordance with the terms of the Creative Commons Attribution (CC BY 4.0) license, which permits others to distribute, remix, adapt and build upon this work, for commercial use, provided the original work is properly cited. See: http://creativecommons.org/licenses/by/4.0/